mesowatch
Asbestos Litigation Trends Reveal Ongoing Health Crisis
divider

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

Jared Reagan

Reading Time: 7 mins

Published On: September 23, 2024

Jared Reagan - administrator

Jared Reagan is a data journalist specializing in public health and environmental issues. He has been with Mesowatch since 2016, where he analyzes and reports on mesothelioma and lung cancer cancer incidence rates, environmental exposure risks, and health-related legal developments. Jared's data-driven approach brings clarity to complex issues, helping readers understand the broader implications of health and environmental policies.

More to Read

divider

September 18, 2024

$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc

>READ

divider

September 11, 2024

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

>READ

divider

September 10, 2024

J&J Raises Talcum Powder Settlement by Another $1.1 Billion

>READ

divider

August 28, 2024

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

>READ

divider

August 27, 2024

J&J’s Talc Legal Battles: Medical Monitoring and Settlement

>READ

divider

August 26, 2024

The Asbestos Lawsuit Process: From Diagnosis to Legal Action

>READ

divider

News & Data

Section divider

FILTER:

Search
Bottom divider
Johnson & Johnson Faces Critical Legal Test in Connecticut
Johnson & Johnson Faces Critical Legal Test in Connecticut

Matthew Davis
5 mins read - September 23, 2024

The first trial in Connecticut involving Johnson & Johnson’s cosmetic talc products has begun, marking a significant legal challenge for the company. The case...

Settlements

FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma

Amna Anees
2 mins read - September 23, 2024

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda) in combination with chemotherapy as a first-line treatment for patients with unresectable...

Treatment

J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement
J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement

Rachel Sasser
4 mins read - September 20, 2024

A subsidiary of Johnson & Johnson (J&J) filed for bankruptcy for the third time on Friday as the healthcare giant attempts to secure a $10 billion settlement to end tens...

Settlements

$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc
$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc

Rachel Sasser
4 mins read - September 18, 2024

A jury awarded over $39 million to a Utah couple in a landmark mesothelioma case involving the use of asbestos-contaminated talc in a surgical procedure. The plaintiffs, Bryce and...

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

Matthew Davis
4 mins read - September 11, 2024

On September 4, Johnson & Johnson boldly announced a $1.1 billion increase to its proposed talc settlement, This would increase the settlement to more than $9 billion paid...

Settlements

J&J Raises Talcum Powder Settlement by Another $1.1 Billion
J&J Raises Talcum Powder Settlement by Another $1.1 Billion

Matthew Davis
4 mins read - September 10, 2024

Johnson & Johnson is planning to pay an additional $1.1 billion in its proposed settlement to clear up tens of thousands of lawsuits alleging the company, and its baby powder...

Settlements


August 28, 2024

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

>READ

divider

August 27, 2024

J&J’s Talc Legal Battles: Medical Monitoring and Settlement

>READ

divider

August 26, 2024

The Asbestos Lawsuit Process: From Diagnosis to Legal Action

>READ

divider

August 24, 2024

Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J

>READ

divider

August 22, 2024

GAG-DP Biomaterial Advances Mesothelioma Research

>READ

divider

August 21, 2024

$59.7M Transfer Triggers Legal Battle Over Asbestos Claims

>READ

divider

August 18, 2024

Pleural and Peritoneal Mesothelioma Found in Female Patient

>READ

divider

August 17, 2024

Study Finds State-Level Trends and Asbestos-Talc Risks

>READ

divider

August 16, 2024

What The J&J $63.4M Talc Lung Cancer Verdict Means for You

>READ

divider

Browse Categories

divider

Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.DMCA.com Protection Status